ArticleScientific reports2026
Transplastomic biofactory for the production of functional human α-lactalbumin for nutritional and therapeutic applications.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Toward Rational Design of Precision-Fermented Milk Proteins: Integrating Cross-Species Selection, Post-Translational Modification, and AI Optimization.Comprehensive reviews in food science and food safety · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The sustainable production of functional human proteins in plants offers a transformative path for developing animal-free nutritional and therapeutic compounds. In this study, we report one of the first expression of human α-lactalbumin (hLA), a key milk protein with nutritional and anticancer properties, via chloroplast genome engineering in Nicotiana tabacum. A codon-optimized hLA gene was introduced into the plastid genome using a synthetic expression cassette under the control of strong plastid regulatory elements. Homoplasmic transplastomic lines were obtained and confirmed via PCR and Southern blot analysis. Immunoblotting and ELISA quantification revealed that hLA accumulated to 23.4% of total soluble protein (TSP), one of the highest levels reported for plastid-expressed human proteins. Far-UV circular dichroism (CD) spectroscopy confirmed that the chloroplast-derived hLA adopted a native-like α-helical structure. Functionally, the recombinant protein successfully activated galactosyltransferase (GalT) in vitro, enabling lactose synthesis at 93% of the rate observed with native hLA. Furthermore, chloroplast-derived hLA was converted into a bioactive HAMLET complex by combining with oleic acid under mild thermal conditions. This complex induced potent apoptosis in human colorectal (WiDr) and breast cancer (MCF-7) cells, reducing viability to less than 8%, as confirmed by MTT and Annexin V/PI assays. These findings establish chloroplasts as an effective platform for high-yield, correctly folded, and functional production of human milk proteins. The ability to generate both enzymatically active and therapeutically functional products from a single plant-based system underscores its potential in food engineering and synthetic biology. This work offers a scalable, sustainable, and dual-purpose strategy for the development of recombinant milk proteins applicable in infant nutrition, functional foods, and plant-made biotherapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.